NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variants

Xuan Ying Poh, Shirley Y. Y. Mah, Aileen Y. Y. Yeoh, Jean-Marc Chavatte, Daniel R. X. Lim, Cheryl C. Y. Tan, Hao Ling Tang, Mihir Gandhi, Nabilah Rahman, Suma Rao, Po Ying Chia, Sapna P. Sadarangani, Yi-Qing Chin, Lisa F. P. Ng, Laurent Renia, Raymond T. P. Lin, David C. Lye, Lin-Fa Wang, Chee Wah T · 2026

Read NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variants by Xuan Ying Poh, Shirley Y. Y. Mah, Aileen Y. Y. Yeoh, Jean-Marc Chavatte, Daniel R. X. Lim, Cheryl C. Y. Tan, Hao Ling Tang, Mihir Gandhi, Nabilah Rahman, Suma Rao, Po Ying Chia, Sapna P. Sadarangani, Yi-Qing Chin, Lisa F. P. Ng, Laurent Renia, Raymond T. P. Lin, David C. Lye, Lin-Fa Wang, Chee Wah T (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13154980.txt.

Description

Xuan Ying Poh and co-authors compare three kinds of COVID-19 boosters head to head in this 2026 trial report. Which platform gives the broadest and longest cover against new variants was untested in one randomized study. The trial gave a second booster to 176 adults who had already had three messenger RNA shots.

The three arms received a single-strain messenger RNA vaccine, a two-strain version, or a protein-based vaccine. All three raised neutralizing antibodies against fresh Omicron branches within a month. The two-strain vaccine peaked highest, reaching about ninety-two percent inhibition against one stubborn subvariant. By twelve months the arms had converged. The protein vaccine started lower but faded slowest, keeping about half its peak antibody level where the others kept a third. The authors say boosters help across platforms, and durability may favor the protein design.

Catalog record

CREATORXuan Ying Poh, Shirley Y. Y. Mah, Aileen Y. Y. Yeoh, Jean-Marc Chavatte, Daniel R. X. Lim, Cheryl C. Y. Tan, Hao Ling Tang, Mihir Gandhi, Nabilah Rahman, Suma Rao, Po Ying Chia, Sapna P. Sadarangani, Yi-Qing Chin, Lisa F. P. Ng, Laurent Renia, Raymond T. P. Lin, David C. Lye, Lin-Fa Wang, Chee Wah T
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13154980

Browse the full library · About the Tower of Babel